{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:39:30Z","timestamp":1790278770182,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>As a terminal stage of various cardiovascular diseases, heart failure is of great concern due to its high mortality rate and limited treatment options. Researchers are currently focusing their efforts on investigating the metabolism of carbohydrates, fatty acids, and amino acids to enhance the prognosis of cardiovascular diseases. Simultaneously, branched-chain amino acids (BCAAs), including leucine, isoleucine, and valine, play significant roles in blood glucose regulation, protein synthesis, and insulin sensitivity. However, disrupted BCAAs metabolism has been associated with conditions such as hypertension, obesity, and atherosclerosis. This article explores intricate metabolic pathways, unveiling the connection between disrupted BCAAs metabolism and the progression of heart failure. Furthermore, the article discusses therapeutic strategies, assesses the impact of BCAAs on cardiac dysfunction, and examines the potential of modulating BCAAs metabolism as a treatment for heart failure. BCAAs and their metabolites are also considered as biomarkers for evaluating cardiac metabolic risk. In conclusion, this article elucidates the multifaceted roles of BCAAs in heart failure and cardiovascular health, providing guidance for future research and intervention measures.<\/jats:p>","DOI":"10.3389\/fnut.2023.1279066","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:07:41Z","timestamp":1700647661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Branched chain amino acids metabolism in heart failure"],"prefix":"10.3389","volume":"10","author":[{"given":"Chenshan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aav0558","article-title":"Branched-chain amino acids in disease","volume":"363","author":"White","year":"2019","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10557-022-07320-4","article-title":"Branched-chain amino acid metabolism in the failing heart","volume":"37","author":"Karwi","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","article-title":"Branched chain amino acids: beyond nutrition metabolism","volume":"19","author":"Nie","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/cvr\/cvr070","article-title":"Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","article-title":"Branched-chain alpha-ketoacids are preferentially reaminated and activate protein synthesis in the heart","volume":"12","author":"Walejko","year":"2021","journal-title":"Nat Commun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.molmet.2021.101261","article-title":"Insulin action, type 2 diabetes, and branched-chain amino acids: a two-way street","volume":"52","author":"White","year":"2021","journal-title":"Mol Metab"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","article-title":"Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids","volume":"29","author":"Neinast","year":"2019","journal-title":"Cell Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","article-title":"Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure","volume":"34","author":"Murashige","year":"2022","journal-title":"Cell Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41401-023-01076-9","article-title":"Cell-autonomous effect of cardiomyocyte branched-chain amino acid catabolism in heart failure in mice","volume":"44","author":"Yu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI38151","article-title":"Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells","volume":"119","author":"Lu","year":"2009","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.nu.04.070184.002205","article-title":"Branched-chain amino acid metabolism","volume":"4","author":"Harper","year":"1984","journal-title":"Annu Rev Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1499S","DOI":"10.1093\/jn\/124.suppl_8.1499S","article-title":"Regulation of branched-chain amino acid catabolism","volume":"124","author":"Harris","year":"1994","journal-title":"J Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance","volume":"22","author":"Jang","year":"2016","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nchembio.1961","article-title":"Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis","volume":"12","author":"Green","year":"2016","journal-title":"Nat Chem Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","article-title":"Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure","volume":"18","author":"Uddin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1373\/clinchem.2015.251710","article-title":"Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED trial","volume":"62","author":"Ruiz-Canela","year":"2016","journal-title":"Clin Chem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"15809","DOI":"10.1038\/s41598-018-34245-6","article-title":"Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI","volume":"8","author":"du","year":"2018","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2018.08.011","article-title":"Increased branched-chain amino acid levels are associated with long-term adverse cardiovascular events in patients with STEMI and acute heart failure","volume":"209","author":"du","year":"2018","journal-title":"Life Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e3253","DOI":"10.1002\/dmrr.3253","article-title":"Circulating branched-chain amino acids and incident heart failure in type 2 diabetes: the Hong Kong diabetes register","volume":"36","author":"Lim","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1753-0407.12645","article-title":"Diabetes and branched-chain amino acids: what is the link?","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J Diabetes"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11892-018-1048-7","article-title":"Branched chain amino acids in metabolic disease","volume":"18","author":"Arany","year":"2018","journal-title":"Curr Diab Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jacl.2019.09.002","article-title":"Association between dyslipidemia and plasma levels of branched-chain amino acids in the Japanese population without diabetes mellitus","volume":"13","author":"Fukushima","year":"2019","journal-title":"J Clin Lipidol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1161\/JAHA.115.003190","article-title":"Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure","volume":"5","author":"Hunter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1021\/acs.jproteome.9b00002","article-title":"Time series characteristics of serum branched-chain amino acids for early diagnosis of chronic heart failure","volume":"18","author":"Li","year":"2019","journal-title":"J Proteome Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","article-title":"Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction","volume":"311","author":"Wang","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"H451","DOI":"10.1152\/ajpheart.00628.2021","article-title":"Metabolomic and transcriptomic signatures of chemogenetic heart failure","volume":"322","author":"Spyropoulos","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.metabol.2013.01.007","article-title":"Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness","volume":"62","author":"Batch","year":"2013","journal-title":"Metabolism"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00125-011-2356-5","article-title":"Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss","volume":"55","author":"Shah","year":"2012","journal-title":"Diabetologia"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"92781","DOI":"10.3390\/jcm9092781","article-title":"A newly developed diabetes risk index, based on lipoprotein subfractions and branched chain amino acids, is associated with incident type 2 diabetes mellitus in the PREVEND cohort","volume":"9","author":"Flores-Guerrero","year":"2020","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejim.2021.07.002","article-title":"A metabolomic index based on lipoprotein subfractions and branched chain amino acids is associated with incident hypertension","volume":"94","author":"Flores-Guerrero","year":"2021","journal-title":"Eur J Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ijcard.2016.08.307","article-title":"Associations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: a twin study","volume":"223","author":"Jennings","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00394-019-02108-z","article-title":"The effect of protein and essential amino acid supplementation on muscle strength and performance in patients with chronic heart failure: a systematic review","volume":"59","author":"Nichols","year":"2020","journal-title":"Eur J Nutr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40256-018-0269-0","article-title":"Effect of Oral branched-chain amino acids on serum albumin concentration in heart failure patients with hypoalbuminemia: results of a preliminary study","volume":"18","author":"Uchino","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","article-title":"Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure-overload induced heart failure","volume":"8","author":"Chen","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1279066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:07:43Z","timestamp":1700647663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1279066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":39,"alternative-id":["10.3389\/fnut.2023.1279066"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1279066","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"article-number":"1279066"}}